Join
Live feed
·
INSIDERFilingvia Quantisnow
NovaBridge Biosciences logo

Chief Medical Officer Dennis Phillip Andrew converted options into 23,695 units of Ordinary Shares and sold $5,606 worth of Ordinary Shares (8,494 units at $0.66), increasing direct ownership by 11% to 157,941 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBP (NovaBridge Biosciences) and more on Quantisnow.